Warning: This is the optimist coming out in me.
Post# of 148165
Is it possible that the FDA has asked us to give them time to review the data before we announce, because the results are good, and they want to understand why/how?
For those that dont remember, we were initially turned down for a COVID trial, because the FDA didnt understand our MOA. It would seem to make sense to me that if we had strong results, they would say "Hold on a second. Let us take a look before you announce this to the world."